CB1 Binding and Signaling Recovered Unevenly After Precipitated Cannabinoid Withdrawal in Rats

After chronic CP55,940 exposure, receptor binding and signaling did not follow the same regional recovery pattern following antagonist-precipitated withdrawal. At 24 hours, some measurements approached control levels while others remained altered.

Chronic exposure changed several receptor measures

The synthetic cannabinoid reduced receptor binding in the striatum, cortex, hippocampus and cerebellum. Agonist-activated G protein responses decreased in the first three regions, but no significant change was detected in the cerebellum. Even before withdrawal, binding loss did not predict the functional result uniformly.

The withdrawal comparison was pharmacologically triggered

At 24 hours after SR141716-precipitated withdrawal, binding tended toward baseline in the striatum and cortex but stayed lower in the hippocampus and cerebellum. G protein responses generally rose toward control levels. A tendency to exceed control in the cerebellum was reported as a trend, not an established significant excess.

Downstream findings depended on exposure state

During chronic treatment, cAMP and PKA measures were unchanged. After withdrawal, a significant increase in the cerebellar cAMP-pathway measurements was reported. The authors proposed relevance to motor aspects of abstinence, without establishing a complete causal chain.

The experiment cannot set a human tolerance-break duration. Its specific lesson is that receptor availability, receptor coupling and downstream signaling can recover differently after a defined antagonist challenge. Calling all of these measurements a single receptor reset would conceal the study's central distinctions.

Related: interpreting cannabis tolerance claims.

Research cited

Rubino T; Viganò D; Massi P; Parolaro D. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940. Journal of neurochemistry (2000). doi:10.1046/j.1471-4159.2000.0752080.x. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

An experimental THC study found lower adrenal-medullary catecholamine stores after acute exposure without a statistically significant decline in a key synthesis enzyme. The changes disappeared with repeated treatment, while circulating hormones followed partly different patterns. Tissue content and enzyme activity were separate measures Acute THC decreased adrenal norepinephrine and epinephrine…

Spread the love

Read Article: Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Some experimental rimonabant analogues produced cannabinoid-like effects in mouse tests but did not reproduce THC's learned drug cue. Other comparisons also separated the compounds from THC, cautioning against equating a similar outward profile with the same pharmacology. Behavioral similarity was only the starting point O-6629 and O-6658 produced dose-dependent effects…

Spread the love

Read Article: Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

A mouse study detected substantial THC behavioral tolerance without significant changes in whole-brain receptor binding or mRNA. The result limits a simple whole-brain explanation while leaving regional or functional changes unresolved. Behavior and biochemical assays were different endpoints Mice received THC twice daily for six and a half days. Testing…

Spread the love

Read Article: Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us